Ropivacaine Molteni 7,5 mg/ml otopina za injekciju ক্রোয়েশিয়া - ক্রোয়েশীয় - HALMED (Agencija za lijekove i medicinske proizvode)

ropivacaine molteni 7,5 mg/ml otopina za injekciju

l. molteni & c. dei f.lli alitti societa di esercizio s.p.a., strada statale 67, fraz. granatieri, scandicci, firenza, italija - ropivakainklorid hidrat - otopina za injekciju - 7,5 mg/ml - urbroj: 1 ml otopine za injekciju sadrži 7,5 mg ropivakainklorida

Ropivakain BioQ Pharma 2 mg/ml otopina za infuziju u sustavu za primjenu ক্রোয়েশিয়া - ক্রোয়েশীয় - HALMED (Agencija za lijekove i medicinske proizvode)

ropivakain bioq pharma 2 mg/ml otopina za infuziju u sustavu za primjenu

bioq pharma b.v., prins bernhardplein 200, amsterdam, nizozemska - ropivakainklorid hidrat - otopina za infuziju u sustavu za primjenu - 2 mg/ml - urbroj: 1 ml otopine za infuziju sadrži ropivakainklorid hidrat što odgovara 2 mg ropivakainklorida

Jemperli ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

jemperli

glaxosmithkline (ireland) limited - dostarlimab - endometrial neoplasms - antineoplastic agents and antibody drug conjugates - jemparli is indicated as monotherapy for the treatment of adult patients with mismatch repair deficient (dmmr)/microsatellite instability-high (msi h) recurrent or advanced endometrial cancer (ec) that has progressed on or following prior treatment with a platinum-containing regimen.

Enspryng ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

enspryng

roche registration gmbh - satralizumab - neuromyelitis optica - imunosupresivi - satralizumab (enspryng) is indicated as a monotherapy or in combination with immunosuppressive therapy (ist) for the treatment of neuromyelitis optica spectrum disorders (nmosd) in adult and adolescent patients from 12 years of age who are anti-aquaporin-4 igg (aqp4-igg) seropositive.

Plegridy ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

plegridy

biogen netherlands b.v. - peginterferon beta-la - multipla skleroza - Иммуностимуляторы, - liječenje recidivnog remitiranja multiple skleroze u odraslih bolesnika.

Primovist 0,25 mmol/ml otopina za injekciju u napunjenoj štrcaljki ক্রোয়েশিয়া - ক্রোয়েশীয় - HALMED (Agencija za lijekove i medicinske proizvode)

primovist 0,25 mmol/ml otopina za injekciju u napunjenoj štrcaljki

bayer d.o.o., radnička cesta 80, zagreb, hrvatska - dinatrijev gadoksetat - otopina za injekciju u napunjenoj štrcaljki - 0,25 mmol/ml - urbroj: 1 ml otopine za injekciju sadrži 181,43 mg dinatrijevog gadoksetata (gd-eob-dtpa dinatrij), što odgovara 0,25 mmol dinatrijevog gadoksetata (gd-eob-dtpa dinatrij)

Takhzyro ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

takhzyro

takeda pharmaceuticals international ag ireland branch - lanadelumab - angioedemas, nasljedni - other hematological agents - takhzyro is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in patients aged 2 years and older.

Libtayo ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

libtayo

regeneron ireland designated activity company (dac) - cemiplimab - karcinom, squamous cell - antineoplastična sredstva - cutaneous squamous cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma (mcscc or lacscc) who are not candidates for curative surgery or curative radiation. basal cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic basal cell carcinoma (labcc or mbcc) who have progressed on or are intolerant to a hedgehog pathway inhibitor (hhi). non-small cell lung cancerlibtayo as monotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (nsclc) expressing pd-l1 (in ≥ 50% tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. libtayo in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with nsclc expressing pd-l1 (in ≥ 1% of tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. cervical cancerlibtayo as monotherapy is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy.

Palynziq ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

palynziq

biomarin international limited - pegvaliase - phenylketonurias - ostali prehrambeni proizvodi i proizvodi metabolizma - palynziq indiciran za liječenje bolesnika s fenilketonurija (pku) u dobi od 16 godina i stariji, koji imaju neprimjeren kontrolu fenilalanin u krvi (nivo fenilalanin u krvi više od 600 мкмоль/l), bez obzira na do upravljanja dostupne mogućnosti liječenja .

HUMALOG 100 jedinica/1 mL otopina za injekciju u ulošku বসনিয়া ও হার্জেগোভিনা - ক্রোয়েশীয় - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

humalog 100 jedinica/1 ml otopina za injekciju u ulošku

eli lilly bh d.o.o. - inzulin lispro - otopina za injekciju u ulošku - 100 jedinica/1 ml - 1 ml otopine za injekciju u ulošku sadrži: 100 jedinica (odgovara 3,5 mg insulina lispro)